CClinicalTrials.gg
TerminatedNCT01510977Updated Feb 13, 2013

Second Bowel Preparation for Colonoscopy Failure

A Phase 4 interventional study of polyethylene glycol, Bisacodyl and polyethylene glycol in Colonoscopy Failure and Poor Bowel Preparation, sponsored by Asan Medical Center. Terminated at 1 site in Korea, Republic of. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2013-02-13.

Sponsored by Asan Medical Center · Phase 4, Interventional, and Diagnostic

Phase
Phase 4
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Colonoscopy is a basic but important tool to diagnose and treat lesions of the colon. Proper colon cleansing is essential for colonoscopy to be performed with a good quality. Inadequate bowel preparation leads to longer colonoscopic insertion time and patient discomfort, as well as inadequate diagnostic yield of colonic lesions. Frequency of colonoscopy failure due to bad bowel preparation is reported to be 0.3% to 6.5 percent, and the rate increases with liver cirrhosis, constipation, dementia, stroke, or administration of tricyclic antidepressants. In case of colonoscopy failure due to bad bowel preparation, the second colonoscopy can be performed with either adding a colon cleansing solution immediately, or it can be performed after a few days with colon cleansing agent together with prokinetics. These different kinds of bowel preparations after first colonoscopy failure have not been compared.

02

Conditions studied

  • Colonoscopy Failure
  • Poor Bowel Preparation

Keywords

  • colonoscopy
  • bowel preparation
03

In context

Lead sponsor

Asan Medical Center is the lead sponsor of 562 studies on the registry; 71 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • First colonoscopy failure due to inadequate bowel preparation

Exclusion criteria

Exclusion Criteria:

  • younger than 18 years old
  • presence of inflammatory bowel disease
  • pregnant
  • lactating
  • refusal
05

Study design

Phase
Phase 4
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
150 participants (actual)

Study arms

  • Active comparator
    PEG

    2L of polyethylene glycol addition immediately after first colonoscopy failure

    Drug: polyethylene glycol

  • Experimental
    PEG + bisacodyl

    One week after initial colonoscopy failure, conventional amount (5L) of polyethylene glycol together with bisacodyl administration

    Drug: polyethylene glycol, Bisacodyl

Interventions

  • Drugpolyethylene glycol, Bisacodyl

    After failure of first colonoscopy, bowel preparation with polyethylene glycol and bisacodyl one week after

  • Drugpolyethylene glycol

    Immediately after first colonoscopy failure, polyethylene glycol 2L addition

06

What researchers measure

Primary outcomes

  1. second colonoscopy failure due to inadequate bowel preparation (PEG+bisdacodyl group)

    Time frame: one week

  2. second colonoscopy failure due to inadequate bowel preparation (PEG group)

    Time frame: within the same day

07

Study locations

1 site
  • Asan Medical Center
    Seoul, 138-736, Korea, Republic of
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 13, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01510977
Lead sponsor
Asan Medical Center
Responsible party
Jeong-Sik Byeon (Clinical Professor, Asan Medical Center) — Principal investigator
First posted
Jan 18, 2012
Start date
Nov 2011
Primary completion
Feb 2013
Completion
Feb 2013
Last update
Feb 13, 2013

Study contacts

Jeong-Sik Byeon, MD, PhD
principal investigator · Asan Medical Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Feb 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion